BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 12783936)

  • 1. New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.
    Marchesani M; Hakkarainen A; Tuomainen TP; Kaikkonen J; Pukkala E; Uimari P; Seppälä E; Matikainen M; Kallioniemi OP; Schleutker J; Lehtimäki T; Salonen JT
    J Natl Cancer Inst; 2003 Jun; 95(11):812-8. PubMed ID: 12783936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of PON1 L55M, Q192R and I102V polymorphisms and their association with prostate cancer risk in Polish men.
    Pol J Pathol; 2020; 71(1):55-61. PubMed ID: 32429655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease.
    Sanghera DK; Aston CE; Saha N; Kamboh MI
    Am J Hum Genet; 1998 Jan; 62(1):36-44. PubMed ID: 9443862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between high-density lipoprotein paraoxonase gene M/L55 polymorphism and carotid atherosclerosis differs in smoking and nonsmoking men.
    Malin R; Loimaala A; Nenonen A; Mercuri M; Vuori I; Pasanen M; Oja P; Bond G; Koivula T; Lehtimäki T
    Metabolism; 2001 Sep; 50(9):1095-101. PubMed ID: 11555845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase 1 Q192R (PON1-192) polymorphism is associated with reduced lipid peroxidation in R-allele-carrier but not in QQ homozygous elderly subjects on a tomato-rich diet.
    Bub A; Barth S; Watzl B; Briviba K; Herbert BM; Lührmann PM; Neuhäuser-Berthold M; Rechkemmer G
    Eur J Nutr; 2002 Dec; 41(6):237-43. PubMed ID: 12474066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Arg allele in position 192 of PON1 is associated with carotid atherosclerosis in subjects with elevated HDLs.
    Gnasso A; Motti C; Irace C; Di Gennaro I; Pujia A; Leto E; Ciamei M; Crivaro A; Bernardini S; Federici G; Cortese C
    Atherosclerosis; 2002 Oct; 164(2):289-95. PubMed ID: 12204800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paraoxonase1-192 polymorphism modulates the nonfatal myocardial infarction risk associated with decreased HDLs.
    Sentí M; Tomás M; Marrugat J; Elosua R;
    Arterioscler Thromb Vasc Biol; 2001 Mar; 21(3):415-20. PubMed ID: 11231922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paraoxonase 1 192 Gln/Arg gene polymorphism and cerebrovascular disease: interaction with type 2 diabetes.
    Koch M; Hering S; Barth C; Ehren M; Enderle MD; Pfohl M
    Exp Clin Endocrinol Diabetes; 2001; 109(3):141-5. PubMed ID: 11409295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymorphism of apoprotein E (APOE), methylenetetrahydrofolate reductase (MTHFR) and paraoxonase (PON1) genes in patients with cerebrovascular disease.
    Topić E; Simundić AM; Ttefanović M; Demarin V; Vuković V; Lovrencić-Huzjan A; Zuntar I
    Clin Chem Lab Med; 2001 Apr; 39(4):346-50. PubMed ID: 11388660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paraoxonase 192 Gln-->Arg polymorphism: an independent risk factor for nonfatal arterial ischemic stroke among young adults.
    Voetsch B; Benke KS; Damasceno BP; Siqueira LH; Loscalzo J
    Stroke; 2002 Jun; 33(6):1459-64. PubMed ID: 12052975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum paraoxonase-1 gene polymorphism and enzyme activity in patients with urolithiasis.
    Atar A; Gedikbasi A; Sonmezay E; Kiraz ZK; Abbasoglu S; Tasci AI; Tugcu V
    Ren Fail; 2016; 38(3):378-82. PubMed ID: 26795139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human paraoxonase 1 gene polymorphisms and the risk of coronary heart disease: a community-based study.
    Watzinger N; Schmidt H; Schumacher M; Schmidt R; Eber B; Fruhwald FM; Zweiker R; Kostner GM; Klein W
    Cardiology; 2002; 98(3):116-22. PubMed ID: 12417809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression.
    Suehiro T; Nakamura T; Inoue M; Shiinoki T; Ikeda Y; Kumon Y; Shindo M; Tanaka H; Hashimoto K
    Atherosclerosis; 2000 Jun; 150(2):295-8. PubMed ID: 10856521
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rogić D; Rako I; Radić Antolić M; Beriša M; Rumora L
    J Clin Pathol; 2018 Nov; 71(11):963-970. PubMed ID: 29858231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
    Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
    Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients.
    Hasselwander O; Savage DA; McMaster D; Loughrey CM; McNamee PT; Middleton D; Nicholls DP; Maxwell AP; Young IS
    Kidney Int; 1999 Jul; 56(1):289-98. PubMed ID: 10411705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paraoxonase 1 (PON1) polymorphisms and prostate cancer in the CPS-II Nutrition Cohort.
    Stevens VL; Rodriguez C; Talbot JT; Pavluck AL; Thun MJ; Calle EE
    Prostate; 2008 Sep; 68(12):1336-40. PubMed ID: 18500687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of age-related myocardial infarction risk and Gln/Arg 192 variants of the human paraoxonase1 gene: the REGICOR study.
    Sentí M; Tomás M; Vila J; Marrugat J; Elosua R; Sala J; Masiá R
    Atherosclerosis; 2001 Jun; 156(2):443-9. PubMed ID: 11395042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paraoxonase-1 codon 192 polymorphism is associated with fasting total cholesterol and LDL-cholesterol concentrations only in postmenopausal women. The REGICOR study.
    Senti M; Tomás M; Elosual R; Sala J; Masiá R; Marrugat J
    Clin Chem Lab Med; 2002 Jul; 40(7):677-83. PubMed ID: 12241013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in the human paraoxonase 1 gene: frequencies, allelic linkages, and association with coronary artery disease.
    Cascorbi I; Laule M; Mrozikiewicz PM; Mrozikiewicz A; Andel C; Baumann G; Roots I; Stangl K
    Pharmacogenetics; 1999 Dec; 9(6):755-61. PubMed ID: 10634138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.